Firms
Samsung Catalyst Fund San Jose, California, US
Samsung Catalyst Fund is Samsung Electronics' multi-stage evergreen venture capital fund that invests in deep-tech infrastructure, AI, and data-enabled platforms. It invests globally with offices in San Jose, Seoul, Tel Aviv, and Paris.
Founded —
Type Venture capital Funds1 2013 corporate launch allocation 2013-02-04 2013-02-04 — USD100m historicalcorporateallocation/launchcommitment notconventionalLPfinalclose, currentevergreencapital/AUMunknown. SeparateSamsungVenturesAmericaUSD1bnnotSCF.
SHOW MORE
Team$550M $550M – $550M San Francisco, California $1M $100K – $5M San Francisco, California — — – — — — – — — — – — — — – — — — – — — — – — — — – — — — – —
SHOW MORE
Investments$— 2026-06-17 Zadar Labs Samsung Catalyst Fund $50M 2026-03-25 Normal Computing Samsung Catalyst Fund , Celesta Capital , Nicholas Brathwaite , ArcTern Ventures , Drive Capital , First Spark Ventures , Micron Ventures $— 2026-02-24 Axelera AI Samsung Catalyst Fund $— 2026-01-28 Eliyan Samsung Catalyst Fund $— 2026 OXMIQ Labs Inc. Samsung Catalyst Fund $— 2026 Velaura Samsung Catalyst Fund $— 2025-12-02 Axiado Samsung Catalyst Fund $— 2025-04-16 Auradine Samsung Catalyst Fund $— 2024-12-04 Axiado Samsung Catalyst Fund $— 2024-11-29 Enfabrica Samsung Catalyst Fund $— 2024-07-16 DreamBig Samsung Catalyst Fund $— 2024-03-25 Eliyan Samsung Catalyst Fund $100M 2023-08-02 Tenstorrent Samsung Catalyst Fund , Eclipse , Greg Reichow $25M 2022-08-02 Avicena Samsung Catalyst Fund $— 2021-05-27 Adia Health Samsung Catalyst Fund $20M 2020-12-14 German Bionic Samsung Catalyst Fund $137M 2020-07-15 Preventice Solutions Samsung Catalyst Fund $— 2020-06-22 AImotive Bosch Ventures , Samsung Catalyst Fund $— 2019-12-10 Wefox Samsung Catalyst Fund $55M 2019-10-22 IonQ Samsung Catalyst Fund , Osage University Partners $11M 2019-08-15 Commsignia Samsung Catalyst Fund , Credo Ventures , Day One Capital , Partech , Romain Lavault $— 2019-03 wefox Group Samsung Catalyst Fund $— 2018-01-01 AImotive Bosch Ventures , Samsung Catalyst Fund $— 2017-10-31 Innoviz Samsung Catalyst Fund $30M 2017-07-20 Graphcore Atomico , Amadeus Capital Partners , Bosch Ventures , Samsung Catalyst Fund $— 2017-04-06 Valens Semiconductor Samsung Catalyst Fund $— 2017 Autotalks Samsung Catalyst Fund $30M 2016-10-31 Graphcore Bosch Ventures , Samsung Catalyst Fund , Hermann Hauser $— 2016-05-19 Afero Samsung Catalyst Fund $— 2016-04-05 Unispectral Bosch Ventures , Samsung Catalyst Fund $— 2015-11-17 Sentiance Samsung Catalyst Fund $— 2015-01 Sentiance Samsung Catalyst Fund $— 2014 Ineda Systems Samsung Catalyst Fund $— Unknown date OXMIQ Labs Inc. Samsung Catalyst Fund $— Unknown date Adia Health Samsung Catalyst Fund $— Unknown date Axiado Samsung Catalyst Fund $— Unknown date Landing AI Samsung Catalyst Fund $37M Unknown date Skylo Technologies Seraphim Space , Innovation Endeavors , Intel Capital , N47 , Samsung Catalyst Fund $60M Unknown date Datrium Lightspeed , New Enterprise Associates , Icon Ventures , Samsung Catalyst Fund $— 2026-02-24 AXELERA AI BV Samsung Catalyst Fund $— 2022 Ada Health Samsung Catalyst Fund $— 2020 German Bionic Systems Samsung Catalyst Fund $— 2018-04-25 Allegro.AI Bosch Ventures , Samsung Catalyst Fund $— 2018 SoundHound Inc. Samsung Catalyst Fund $— 2017 SoundHound Inc. Samsung Catalyst Fund $— 2017 TetraVue Bosch Ventures , Samsung Catalyst Fund $— Unknown date Solarisbank AG Samsung Catalyst Fund $— Unknown date Velaura AI Samsung Catalyst Fund $— Unknown date Axelera Samsung Catalyst Fund
SHOW MORE
team@apexlogos.ai · 57 minutes ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities.
Fund size, structure and stages
| Vehicle or metric | Amount/status/date | Interpretation and source |
| --- | --- | --- |
| Initial Samsung Catalyst Fund commitment | USD 100 million; announced 2013-02-04 | Historical corporate allocation/launch commitment. Contemporary reporting describes a launch, not a conventional third-party LP final close. [AllThingsD](https://allthingsd.com/20130204/samsung-aims-to-boost-u-s-presence-with-1-1-billion-in-venture-funds/ ) (2013-02-04); [Global Corporate Venturing](https://globalventuring.com/blog/2013/02/05/samsung-adds-100m-start-up-fund/ ) (2013-02-05). |
| Current evergreen capital/AUM | Not disclosed in checked primary sources | Evergreen multi-stage structure confirmed in investee announcements. USD 100 million is not established current AUM or remaining capital. [Avicena release](https://avicena.tech/press-release-08-02-2022/ ) (2022-08-02); [Tenstorrent release](https://tenstorrent.com/newsroom/tenstorrent-raises-a-strategic-up-round ) (2023-08-02/03). |
| Samsung Ventures America Fund | Historical USD 1 billion figure | Separate vehicle; do not add it to SCF. [AllThingsD](https://allthingsd.com/20130204/samsung-aims-to-boost-u-s-presence-with-1-1-billion-in-venture-funds/ ) (2013-02-04). |
| Check sizes, numbered funds, new final closes or replenishment | Not verified | Searches for newer SCF funds/budget, the current official website/news and investee releases did not establish a newer named fund amount. This is latest-known historical disclosure, not a claim that USD 100 million is its latest/current size. |
Investment strategy is explicitly multi-stage in SCF’s [2018 strategy article](https://samsungcatalyst.com/insights/samsung-catalyst-fund-the-sherpa-for-your-startup-journey/ ) (2018-12-05) and the 2023 Tenstorrent release. The initial 2013 launch was early-stage-oriented; this historical remit should not override the later multi-stage mandate. Verified Series A transactions include Avicena and German Bionic. Later strategic rounds and growth funding demonstrate broader execution, but round labels must follow each source. No reliable minimum/maximum entry stage or check range was verified.
Funds recorded in Adex after this review:
| Fund | Disclosed amount | Announcement / filing date |
| --- | --- | --- |
| 2013 corporate launch allocation | Undisclosed / unverified | 2013-02-04 | SHOW MORE
team@apexlogos.ai · 2 hours ago
Match research 2026-10-06 / GoldiSamsungCatalystFund / sha256:3e67c5a4a68159bf2ca6be201900c08a762d2d3a6387409287f2ae01e913b3d0 / part 2 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
**No verified neurotech investment found in the sources checked.** The snapshot, official portfolio/news, Signal firm page, the named financing releases above and searches combining SCF with brain, neurotechnology, EEG, Neuralink and Synchron yielded no directly attributable brain sensing, neural stimulation, BCI or other neural-interface financing. This is a bounded search result, not proof that SCF has never invested in neurotechnology.
- **Preventice Solutions** is a verified SCF investment, but an adjacent cardiac-monitoring company. Its USD 137 million Series B on 2020-07-15 included SCF as an existing investor, with Vivo leading and Novo joining. The cited technology concerns ambulatory cardiac/remote monitoring, not neural activity. [Company-issued release](https://www.prnewswire.com/news-releases/preventice-solutions-announces-137-million-series-b-financing-led-by-vivo-capital-301093940.html ) (2020-07-15).
- **Ada Health** appears on the official SCF portfolio, but its symptom assessment/care navigation AI is not direct neurotech. Its 2022 official release establishes a USD 30 million extension bringing Series B to USD 120 million, following USD 90 million in May 2021; it does not name SCF among those round participants. Portfolio attribution is supported; participation in these specific rounds remains unverified. [Ada release](https://about.ada.com/press/220210-ada-health-extends-series-b-to-120-million/ ) (2022-02-10); [SCF portfolio](https://samsungcatalyst.com/ ) (accessed 2026-10-06).
- German Bionic’s exoskeleton is assistive robotics, without evidence here of a neural-control mechanism. AI chip companies’ artificial neural networks are computing, not neurotechnology.
## Conflicts, gaps and later Adex review notes
1. Preserve exact firm ID. The `Goldi` prefix is the captured ID, not part of the public firm name. Preserve SCF attribution rather than grouping all Samsung arms.
2. Review round totals incorrectly populated as investor `amount` in the snapshot: Tenstorrent USD 100 million, Normal USD 50 million, Avicena USD 25 million and many others are total rounds. No SCF contribution amount is established by these sources.
3. Review duplicate company/round representations: Axelera AI / AXELERA AI BV / Axelera; German Bionic / German Bionic Systems; Velaura / Velaura AI; repeated Axiado, OXMIQ and Ada/Adia claims. Do not blindly merge legally distinct entities, but investigate likely aliases and identical transactions.
4. The snapshot’s **Adia Health** rows cite **Ada Health** stories; review company identity. Its Series C tag for the 2021 USD 90 million raise conflicts with Ada’s official Series B history. The USD 120 million 2022 figure is cumulative Series B including an extension, not a new USD 120 million round; SCF’s participation in either tranche was not independently confirmed here.
5. Normal Computing’s Series C tag conflicts with the source’s unlabelled strategic funding. Axelera’s Series D tag is not supported by its cited official release. Tenstorrent has a one-day page/dateline date discrepancy. Preserve source precision rather than invent a stage or close date.
6. IonQ’s directly attributable 2019 investment is missing from the snapshot and is a strong later review candidate. Current ownership, exact investment amount and stage are unverified.
7. Website team identifies David Goldschmidt as head and Ray Schuder as senior investment director. Snapshot roles have no dates; former or historical team members should not be treated as current without role-specific verification. [David profile](https://samsungcatalyst.com/team/david-dede-goldschmidt/ ); [Ray profile](https://samsungcatalyst.com/team/ray-schuder/ ) (both undated, accessed 2026-10-06). Ray’s prior-firm exits do not prove SCF portfolio attribution.
8. No current AUM, evergreen allocation, check sizes, portfolio completeness, formal fund-close evidence or verified direct neurotech transaction was established. This file verifies representative technically strong transactions, not all 48 snapshot participation rows. Other snapshot items, including ordinary insurance/fintech services, should not automatically become deep-tech entries.
All web sources were accessed 2026-10-06. Dates given above are publication/announcement dates, not inferred legal-close dates unless the issuer explicitly says the financing closed. PR Newswire items are company-issued primary disclosures, not independently reported corroboration. Historical fund commitment is supported by contemporary reputable reporting; technical performance claims remain attributed to issuers. Research only: no Adex/database update, MCP Patch or commit was performed. SHOW MORE
team@apexlogos.ai · 2 hours ago
Match research 2026-10-06 / GoldiSamsungCatalystFund / sha256:3e67c5a4a68159bf2ca6be201900c08a762d2d3a6387409287f2ae01e913b3d0 / part 1 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
# Samsung Catalyst Fund
- Exact Adex ID: `GoldiSamsungCatalystFund`
- Canonical Adex URL: https://adex.page/firms/GoldiSamsungCatalystFund
- Research date: 2026-10-06
- Status: complete research file; remaining public-information gaps are explicit below.
## Identity and summary
Samsung Catalyst Fund (SCF) is Samsung Electronics’ evergreen, multi-stage corporate venture investor. Its current website identifies it as US-based, fully owned by Samsung Electronics, investing globally, with independent investment decisions. It focuses on AI infrastructure, semiconductors and other technically demanding infrastructure. Strong directly attributable examples include IonQ, Tenstorrent, Avicena, Axelera AI, Normal Computing and German Bionic. No verified neurotech investment found in the sources checked. [Official website](https://samsungcatalyst.com/ ) (undated, accessed 2026-10-06); [Tenstorrent announcement](https://tenstorrent.com/newsroom/tenstorrent-raises-a-strategic-up-round ) (2023-08-02 page date, 2023-08-03 release dateline).
SCF is distinct from Samsung NEXT, Samsung Venture Investment/Samsung Ventures, Samsung Securities and Samsung’s internal R&D programs. A generic Samsung investment or employee’s earlier investment is insufficient for SCF attribution.
## Adex and NFX Signal starting evidence
The exact saved MCP Search snapshot `_sources/GoldiSamsungCatalystFund.adex.json` was retrieved 2026-10-06. It describes deep-tech infrastructure, AI and data platforms; lists San Jose, Seoul, Tel Aviv and Paris in its description; has null check minimum, maximum and sweet spot; contains ten role records and 48 investment participation rows. Snapshot sources include the official website, Signal and Goldi intelligence. These remain starting claims, not independently verified facts. It includes IonQ neither as an investment row nor with the source checked here, despite strong primary evidence below.
[NFX Signal firm page](https://signal.nfx.com/firms/samsung-catalyst-fund ) was directly read on 2026-10-06. The accessible page identifies San Francisco, California and co-investing firms (including Nokia Growth Partners, NEA, General Catalyst and Hitachi Ventures). Its team heading exposes no individual profiles in the returned text, and no stages, checks, fund size or attributable transactions were available. Do not infer these from the co-investor list. This geographic field conflicts with the official San Jose headquarters. The official location section lists San Jose, Seoul and Tel Aviv, without Paris; Paris is therefore unconfirmed as a current office. [Official website](https://samsungcatalyst.com/ ) (undated, accessed 2026-10-06).
## Fund size, structure and stages
| Vehicle or metric | Amount/status/date | Interpretation and source |
| --- | --- | --- |
| Initial Samsung Catalyst Fund commitment | USD 100 million; announced 2013-02-04 | Historical corporate allocation/launch commitment. Contemporary reporting describes a launch, not a conventional third-party LP final close. [AllThingsD](https://allthingsd.com/20130204/samsung-aims-to-boost-u-s-presence-with-1-1-billion-in-venture-funds/ ) (2013-02-04); [Global Corporate Venturing](https://globalventuring.com/blog/2013/02/05/samsung-adds-100m-start-up-fund/ ) (2013-02-05). |
| Current evergreen capital/AUM | Not disclosed in checked primary sources | Evergreen multi-stage structure confirmed in investee announcements. USD 100 million is not established current AUM or remaining capital. [Avicena release](https://avicena.tech/press-release-08-02-2022/ ) (2022-08-02); [Tenstorrent release](https://tenstorrent.com/newsroom/tenstorrent-raises-a-strategic-up-round ) (2023-08-02/03). |
| Samsung Ventures America Fund | Historical USD 1 billion figure | Separate vehicle; do not add it to SCF. [AllThingsD](https://allthingsd.com/20130204/samsung-aims-to-boost-u-s-presence-with-1-1-billion-in-venture-funds/ ) (2013-02-04). |
| Check sizes, numbered funds, new final closes or replenishment | Not verified | Searches for newer SCF funds/budget, the current official website/news and investee releases did not establish a newer named fund amount. This is latest-known historical disclosure, not a claim that USD 100 million is its latest/current size. |
Investment strategy is explicitly multi-stage in SCF’s [2018 strategy article](https://samsungcatalyst.com/insights/samsung-catalyst-fund-the-sherpa-for-your-startup-journey/ ) (2018-12-05) and the 2023 Tenstorrent release. The initial 2013 launch was early-stage-oriented; this historical remit should not override the later multi-stage mandate. Verified Series A transactions include Avicena and German Bionic. Later strategic rounds and growth funding demonstrate broader execution, but round labels must follow each source. No reliable minimum/maximum entry stage or check range was verified.
## Verified previous deep-tech investments
Round figures below are company-wide financings, never SCF’s individual contribution unless disclosed. Technology descriptions explain classification; they do not independently validate company performance claims.
| Company and rationale | SCF attribution, round and date | Supporting URL/date |
| --- | --- | --- |
| **IonQ** — trapped-ion quantum computers, requiring quantum hardware and control engineering | Co-led with Mubadala Capital a USD 55 million round; company total raised then USD 77 million. No stage label inferred. Announcement 2019-10-22. | [IonQ investor announcement](https://investors.ionq.com/news/news-details/2019/IonQ-Secures-55-Million-in-Funding-to-Bring-Quantum-Computing-from-the-Lab-to-the-Enterprise/default.aspx ) (2019-10-22); [SCF investment rationale](https://samsungcatalyst.com/insights/ionq-an-investment-in-our-quantum-future/ ) (undated, accessed 2026-10-06). |
| **German Bionic** — powered connected industrial exoskeletons and cloud robotics | USD 20 million Series A closed; led by SCF and MIG AG, with other participants. 2020-12-14. Powered assistance alone does not establish a neural interface. | [Company-issued financing announcement](https://www.prnewswire.com/news-releases/robotics-specialist-german-bionic-receives-us-20-million-in-series-a-financing-301191442.html ) (2020-12-14). |
| **Avicena** — GaN microLED arrays and photonic chip-to-chip optical interconnects | Participated alongside Cerberus, Clear Ventures and Micron Ventures in USD 25 million Series A; 2022-08-02. | [Avicena announcement](https://avicena.tech/press-release-08-02-2022/ ) (2022-08-02). |
| **Tenstorrent** — AI processors, RISC-V IP, AI chiplets and neural-network compiler engineering | Co-led USD 100 million closed strategic financing with Hyundai Motor Group. Page dated 2023-08-02, release dateline 2023-08-03. No Series C designation inferred from this release. | [Tenstorrent announcement](https://tenstorrent.com/newsroom/tenstorrent-raises-a-strategic-up-round ) (2023-08-02/03). |
| **Axelera AI** — purpose-built inference semiconductors for edge compute, co-designed hardware/software architecture | Existing investor participating in more than USD 250 million financing announced 2026-02-24, led by Innovation Industries. Official release does not call it Series D. Its more than USD 450 million cumulative equity/grants/debt is a separate total. | [Axelera announcement](https://axelera.ai/news/axelera-ai-secures-more-than-250-million-funding-on-global-commercial-growth ) (2026-02-24). |
| **Normal Computing** — AI-based formalization and verification for chip design, plus thermodynamic computing silicon | Led USD 50 million strategic funding; total company funding exceeds USD 85 million. 2026-03-25. Source does not identify Series C, despite Adex label. Hardware program and efficiency forecasts are issuer claims, not verified benchmark results. | [Normal company release](https://www.prnewswire.com/news-releases/normal-computing-raises-50m-led-by-samsung-catalyst-to-accelerate-silicon-design-and-solve-ai-hardware-energy-crisis-302724819.html ) (2026-03-25). |
The current [SCF news archive](https://samsungcatalyst.com/news/ ) (accessed 2026-10-06) also supplies dated leads: OXMIQ USD 35 million Series A co-led by SCF (2026-07-01), Zadar Labs USD 17 million Series A for imaging radar (2026-06-17), Eliyan USD 145 million Series C for electro-optical interconnects (2026-07-29), and Velaura AI USD 110 million Series A (2026-08-18). These are firm-published leads rather than investee-confirmed rows in the table above; individual checks and all co-investors are not established. Its September 2026 Mistral and May 2026 Anthropic headlines say Samsung and should retain that generic attribution until the investing legal entity/vehicle is verified.
## Neurotech assessment and adjacent investments SHOW MORE
team@apexlogos.ai · 22 days ago
MATCH